Clinical trial
Hypomagnesemia as a Marker of Diabeteiv Nephropathy
NCT03690180 is registered in ClinicalTrials.gov with Fayoum University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hypomagnesemia as a Marker of Diabeteiv Nephropathy
- Lead sponsor
- Fayoum University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2018
- Completion date
- February 28, 2018
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.